Investigación > Cáncer

Grupo de investigación de biomarcadores en cáncer (GReBiC)

Número de publicaciones
514
Buscador de publicaciones
  • Martinez-Jañez, N; García-Saenz, JA; Pernas, S; Bermejo, B; Morales, S; Guerra, J; Silva, J; Manso, L; Ciruelos, E; Tolosa, P; Sánchez-Bayona, R; Alva, M; Calabuig-Fariñas, S; Gallach, S; Muinelo-Romay, L; Piñeiro-Yáñez, E; Caleiras, E; Bueno, MJ; Mouron, S; Quintela-Fandino, M

    Co-clinical trial targeting ER, FGFR and CDK4/6 in resistant hormone-positive breast cancer with FGFR alterations

    npj Precision Oncology 9 343-343. .

    [doi:10.1038/s41698-025-01106-1]

  • Porcel, JM; Porcel, L; Campo-Linares, R

    Point-of-care ultrasound in pulmonary and pleural infections

    MEDICINA CLINICA 165 107191-107191. .

    [doi:10.1016/j.medcli.2025.107191]

  • Suárez-Antelo, J; Ferreiro, L; Porcel, JM; Toubes, ME; Lado-Baleato, O; Rodríguez-Núnez, N; Ricoy, J; Lama, A; Golpe, A; Alvarez-Dobaño, JM; Gude, F; Valdés, L

    Predictors of Survival in Metastatic Malignant Pleural Effusions: The GASENT Score

    ARCHIVOS DE BRONCONEUMOLOGIA 61 680-689. .

    [doi:10.1016/j.arbres.2025.04.001]

  • Sánchez-Maure, M; Rendón-Ramírez, EJ; Quintana, JOJ; Nañez-Terreros, H; Solis, RC; Cedillo-Huerta, HE; Magaña-García, AD; Medrano-Juárez, S; Nava-Rodriguez, O; Obeso, J; Porcel, JM

    Association of pleural effusion on thoracic ultrasound with severe acute pancreatitis and mortality

    BMC GASTROENTEROLOGY 25 730-730. .

    [doi:10.1186/s12876-025-04343-7]

  • Ramirez-Hidalgo, MF; Mira-Flores, M; Diaz, ML; Tueros-Farfan, L; Florensa, PS; Mormeneo-Bayo, S; Jover-Sáenz,

    Non-Surgical Exceptional Management of Inoperable Hydatidosis with Radiotherapy: Case Report and Review of Literature

    AMERICAN JOURNAL OF TROPICAL MEDICINE AND HYGIENE 113 836-838. .

    [doi:10.4269/ajtmh.25-0181]

  • Porcel, JM; Sorolla, MA

    MicroRNA expression in pleural fluid as a diagnostic biomarker of malignant pleural effusion: promise, pragmatism, and the path forward

    Translational Lung Cancer Research 14 3284-3291. .

    [doi:10.21037/tlcr-2025-844]

  • Manso, L; Sánchez-Bayona, R; Guerra, JA; Cortes-Salgado, A; Cejalvo, JM; Garcia-Saenz, JA; Morales, S; González-Cortijo, L; Mourón, S; Bueno, MJ; Garma, LD; Quintela-Fandino, M

    A Phase IB Study of Binimetinib and Palbociclib in Molecularly Selected Advanced Triple-Negative Breast Cancer

    Cancer Research Communications 5 1728-1737. .

    [doi:10.1158/2767-9764.CRC-25-0428]

  • Yang, WP; Zhou, Q; Porcel, JM; Wang, J; Wu, CX; Zavialov, AV

    A rapid antigen test to detect adenosine deaminase 2 (ADA2) in biological fluids and its application in clinical diagnostics

    Frontiers in Immunology 16 1633219-1633219. .

    [doi:10.3389/fimmu.2025.1633219]

  • Fjaellegaard, K; Ahmadzai, S; Porcel, JM; Mei, F; Shaw, JA; Bodtger, U

    Pleural fluid biomarkers to predict response to pleurodesis or indwelling pleural catheter for malignant pleural effusion: still a long way to go

    Respiratory Research 26 259-259. .

    [doi:10.1186/s12931-025-03288-5]

  • Yan, L; Cha, SN; Niu, Y; Wen, JX; Zhao, W; Yan, C; Zhu, HZ; Wang, YJ; Hai, L; Jiang, TW; Zhou, QH; Porcel, JM; Zheng, WQ; Hu, ZD

    Pleural fluid C-C class chemokines 22 and pleural effusion due to heart failure: a prospective and double-blind diagnostic accuracy test

    BMJ Open Respiratory Research 12 -. .

    [doi:10.1136/bmjresp-2024-002823]

  • Skaldin, M; Porcel, JM; Lamminmäki, U; Bielsa, S; Zavialov, AV

    Developing and validating anti-ADA2 single-chain antibodies coupled to alkaline phosphatase for diagnosing pleural tuberculosis

    Frontiers in Immunology 16 1646134-1646134. .

    [doi:10.3389/fimmu.2025.1646134]

  • López-Miranda, E; Pérez-García, JM; Gión, M; Ribelles, N; Cortez-Castedo, P; Alonso-Romero, JL; García, MM; González-Santiago, S; Bermejo, B; Morales, S; Carañana, V; Garrigós, L; Fernández-Pinto, M; Garcia-Vicente, S; García-Sanz, A; Mena-Molina, A; Boix, O; Alcalá-López, D; Llombart-Cussac, A; Cortés, J

    Ipatasertib combined with non-taxane chemotherapy for patients with previously treated advanced triple-negative breast cancer: the PATHFINDER phase IIa trial

    BREAST CANCER RESEARCH 27 141-141. .

    [doi:10.1186/s13058-025-02089-4]